Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Risk Score Reveals Hidden Hypertension-Related Organ Damage

By HospiMedica International staff writers
Posted on 24 Jun 2026

Hypertension is a leading driver of cardiovascular, cerebrovascular, and renal morbidity, yet organ injury often remains clinically silent until late. More...

Reliance on blood pressure readings alone can miss patients who are progressing toward adverse events. This gap complicates risk stratification and timing of intervention in routine care. Researchers have now developed an artificial intelligence tool to map multiorgan injury patterns in people with high blood pressure.

HyperScore, an artificial intelligence (AI)-derived score led by the University of Oxford, estimates hypertension-related damage across multiple organs before a major cardiovascular event. The team also identified six distinct disease patterns, termed HyperTrajectories, that describe how organ systems are affected in different individuals. This framework is intended to capture heterogeneous pathways of disease that are not apparent from conventional clinic measurements alone.

To build HyperScore, investigators integrated hundreds of measures into a single model. Inputs reflected the heart, brain, kidneys, vasculature, lungs, liver, and metabolic profiles. The goal was to characterize the systemic burden of hypertension beyond a single blood pressure value.

The study applied machine learning to imaging and clinical data from more than 27,000 UK Biobank participants. External validation was performed in a further 5,500 participants from the U.S.-based Atherosclerosis Risk in Communities study. Individuals with higher HyperScores were more likely to experience future cardiovascular problems even when blood pressure alone did not separate risk. Brain changes detected on magnetic resonance imaging were among the strongest indicators associated with hypertension-related damage.

The work, published in Circulation on June 21, 2026, suggests potential use in earlier identification of people beginning to develop problems that could lead to stroke, heart failure, or kidney disease. The researchers emphasize that the approach is at an early stage and is not yet ready for routine clinical use. Further development and clinical studies are needed before adoption in care pathways.

“High blood pressure affects people very differently. Some individuals develop significant damage to the heart, brain or kidneys even when blood pressure is only mildly elevated, while others appear relatively protected despite longstanding hypertension. Our findings suggest that AI methods may help us move beyond treating hypertension based purely on blood pressure numbers, toward a more personalized understanding of how the disease affects the body,” said Dr. Mohanad Alkhodari, first author of the study and a current visiting researcher at the Radcliffe Department of Medicine's Clinical Cardiovascular Research Facility.

Related Links
University of Oxford's Radcliffe Department of Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.